Abstract
Port wine stain (PWS) is a congenital vascular malformation involving human skin. Approximately 15–20% of children a facial PWS involving the ophthalmic (V1) trigeminal dermatome are at risk for Sturge Weber syndrome (SWS), a neurocutaneous disorder with vascular malformations in the cerebral cortex on the same side of the facial PWS lesions. Recently, evidence has surfaced that advanced our understanding of the pathogenesis of PWS/SWS, including discoveries of somatic genetic mutations (GNAQ, PI3K), MAPK and PI3K aberrant activations, and molecular phenotypes of PWS endothelial cells. In this review, we summarize current knowledge on the etiology and pathology of PWS/SWS based on evidence that the activation of MAPK and/or PI3K contributes to the malformations, as well as potential futuristic treatment approaches targeting these aberrantly dysregulated signaling pathways. Current data support that: (1) PWS is a multifactorial malformation involving the entire physiological structure of human skin; (2) PWS should be pathoanatomically re-defined as “a malformation resulting from differentiation-impaired endothelial cells with a progressive dilatation of immature venule-like vasculatures”; (3) dysregulation of vascular MAPK and/or PI3K signaling during human embryonic development plays a part in the pathogenesis and progression of PWS/SWS; and (4) sporadic low frequency somatic mutations, such as GNAQ, PI3K, work as team players but not as a lone wolf, contributing to the development of vascular phenotypes. We also address many crucial questions yet to be answered in the future research investigations.
Highlights
Port wine stain (PWS), known as congenital capillary vascular malformation, results from differentiation-impaired endothelial cells (ECs) in human skin with a progressive dilatation of immature venule-like vasculatures [1]
This knowledge can be categorized into four aspects: (1) the fundamental pathological and histological phenotypes of a variety of cell types in PWS/Sturge Weber syndrome (SWS) lesions; (2) the molecular profiles of PWS vasculatures; (3) the germline and somatic mutations in PWS/SWS lesions; and (4) development of new treatment options, such as the expansion of light-based treatments from pulsed dye laser (PDL) to photodynamic therapy (PDT)
These data have provided cellular, molecular and genetic support for several new concepts of PWS/SWS: (1) PWS/SWS is a multifactorial malformation involving the peripheral vascular system, but the entire physiological structure of human skin; (2) PWS ECs are differentiation-impaired ECs showing with a progressive dilatation of immature venule-like vasculatures; (3) the primary contributing signaling pathway to the pathogenesis and progression of PWS/SWS is the dysregulated vascular mitogen-activated protein kinase (MAPK) and/or phosphatidylinositol 3-kinase (PI3K) signaling pathways which occurs during human embryonic development (Figure 2); (4) somatic mutations, such as GNAQ, PI3K, are team players but not as a lone wolf
Summary
Port wine stain (PWS), known as congenital capillary vascular malformation, results from differentiation-impaired endothelial cells (ECs) in human skin with a progressive dilatation of immature venule-like vasculatures [1]. 15–20% of children with an ophthalmic (V1) dermatomal facial PWS are at risk for Sturge Weber syndrome (SWS) [4], a neurocutaneous disorder with vascular malformations in the cerebral cortex on the same side of the facial PWS [5,6]. Evidence has systematically documented the pathological characteristics of PWS/SWS, including detailed transmission electron microscopy (TEM) ultrastructure from infantile, hypertrophic and nodular PWS, molecular profiles and upregulation of exocytosis of PWS ECs [1,37,38,39] These recent data have demonstrated that PWS is a multifactorial malformation, involving the vasculature, and other structures within the dermis. The uncovering of these pathological phenotypes has greatly enhanced our understanding of the etiology and progression of the malformation at the cellular level
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.